Danish leader will face a challenging landscape among competitors ...

How three physicians’ own weight struggles reshape patient care, challenge bias, and push systemic change in treating obesity ...

The adoption of the new “clinical obesity” definition alters prevalence estimates of obesity in many parts of the world ...

University of Kentucky Markey Cancer Center researchers have identified a protein that could be a promising treatment target ...

A recent study conducted on humans showed promising results for a new weight loss compound known as SANA. The molecule works ...

A new genetic tool — called a polygenic risk score (PGS) — uses DNA data from over five million people to predict adult ...

The development of obesity and type 2 diabetes during childhood may inhibit bone formation and could lead to a higher risk ...

Wegovy, the blockbuster weight-loss drug, is now available in Singapore more than two years after it was approved by the ...

Obesity elevates the risk of at least 13 major cancers, including those of the breast, colon and liver. It also impairs immune responses that target tumors and are stimulated by cancer immunotherapies ...

Research indicates that early eating habits may lower genetic obesity risk, enhancing weight loss maintenance in at-risk ...

Novo Nordisk ( NVO) continued its downward spiral and fell 3.8% in premarket trade, a day after the Danish drugmaker slashed ...

IT often strikes without symptoms until it’s too late – but spotting the early red flags of liver cancer could save your life ...